Why NRx Pharmaceuticals Stock Is Jumping Again on Thursday

Why NRx Pharmaceuticals Stock Is Jumping Again on Thursday

Shares of NRx Pharmaceuticals (NASDAQ: NRXP) are rising sharply for the second time this week. Today, investors are excited about clinical trial results for aviptadil, a potential new treatment for respiratory failure caused by COVID-19. The biotech stock was up 33.8% as of 10:54 a.m. EDT on Thursday.